Authors: Ruottinen, HM Niinivirta, M Bergman, J Oikonen, V Solin, O Eskola, O Eronen, E Sonninen, P Rinne, UK

Citation: Hm. Ruottinen et al., Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging, SYNAPSE, 40(1), 2001, pp. 19-26

Authors: Nuutinen, J Sonninen, P Lehikoinen, P Sutinen, E Valavaara, R Eronen, E Norrgard, S Kulmala, J Teras, M Minn, H

Citation: J. Nuutinen et al., Radiotherapy treatment planning and long-term follow-up with [C-11]methionine pet in patients with low-grade astrocytoma, INT J RAD O, 48(1), 2000, pp. 43-52

Authors: Hietala, J Syvalahti, E Vilkman, H Vuorio, K Rakkolainen, V Bergman, J Haaparanta, M Solin, O Kuoppamaki, M Eronen, E Ruotsalainen, U Salokangas, RKR

Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50

Authors: Rinne, JO Bergman, J Ruottinen, H Haaparanta, M Eronen, E Oikonen, V Sonninen, P Solin, O

Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124

Authors: Pitkanen, OP Laine, H Kemppainen, J Eronen, E Alanen, A Raitakari, M Kirvela, O Ruotsalainen, U Knuuti, J Koivisto, VA Nuutila, P

Citation: Op. Pitkanen et al., Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake, J PHYSL LON, 521(3), 1999, pp. 729-737